Combination drug treatment could be effective against malignant peripheral nerve sheath tumors

A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) -; soft tissue tumors that are stubbornly resistant to chemotherapy and radiation -; according to a laboratory study led by researchers at the Johns Hopkins Kimmel Cancer Center.

FDA offers new guidelines for Covid-19 vaccine

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we talk

June 17, 2024

MemTrax continuous recognition test shows promise in early detection of Alzheimer’s disease

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 12,

July 14, 2023

ESC 2024: Single-pill hypertension combo delivers positive results – Pharmaceutical Technology

Caption: At the ESC Congress, the George Institute for Global Health presented positive data from a clinical trial investigating a single pill-combination for mild-to-moderate hypertension.

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.